Innospec (IOSP) 2026 年第三季財報法說會：營收成長與利潤率提升

Innospec Inc. (NASDAQ: IOSP) 在 2026 財年第三季法說會上公布全面性成長，三大營運部門的營收與營業利益均實現增長。特種化學品 (Performance Chemicals) 部門引領利潤改善，而管理層預計北卡羅來納州工廠升級及油田服務 (Oilfield Services) 業務活絡將進一步推動未來進展。

重點摘要

• 第三季營收年增 7% 至 4.736 億美元，毛利率擴增 0.9 個百分點至 27.3%。
• 調整後 EBITDA 從 4,420 萬美元增至 5,140 萬美元。調整後 EPS 從 1.12 美元增至 1.29 美元。
• 儘管銷量下滑 5%，特種化學品部門營業利益仍驟升 84% 至 1,690 萬美元，毛利率改善至 18.8%。
• 油田服務部門營收成長 13%，營業利益成長 40%，但中東地區的業務延宕與居高不下的原料成本壓抑了本季表現。
• Innospec 截至 9 月底擁有 2.519 億美元的現金及現金等價物，且無任何債務。管理層預估第四季自由現金流將達 4,000 萬至 5,000 萬美元。
• 董事會將半年股息提高至每股 0.94 美元，相當於年度股息成長 9%。

主要財務業績

業務與營運表現

特種化學品部門

營收增長 6% 至 1.805 億美元。受原料價格上漲推動，價格與產品組合帶動了 12% 的正面貢獻，抵銷了 5% 的銷量減少及 1% 的負面匯率影響。

毛利率從 15.1% 擴增至 18.8%，營業利益大增 84% 至 1,690 萬美元。管理層預期北卡羅來納州工廠的效率升級將於年底完工。該工程旨在提升個人護理及其他現有產品的產能、生產力與良率。

公司無需重新取得客戶對產品的認證，但管理層指出收復失利的銷售額仍需時間。預計成長將呈現循序漸進的上升軌跡，而非大幅反彈。Innospec 也計劃優先考慮新技術與高毛利產品，而非用大宗商品填滿升級後的工廠。

燃料特殊化學品部門

在銷量成長 3% 以及價格與產品組合貢獻 2% 的支撐下，營收成長 5% 至 1.807 億美元。毛利率為 31.5%，營業利益成長 1% 至 3,560 萬美元。

管理層表示，儘管轉嫁定價存在時間滯後，該業務仍繼續透過合約定價機制管理波動的原料與運費成本。公司將燃料特殊化學品定位為毛利率穩定的業務，並預期強勁表現與季節性需求將持續。

油田服務部門

營收成長 13% 至 1.124 億美元。受產品組合較弱影響，毛利率下降 1.8 個百分點至 28.2%，但營業利益成長 40% 至 670 萬美元。

擴建後的減阻劑工廠產量增加，支撐了業務成長。然而，中東傳統生產與增產刺激業務的延宕，加上原料成本攀升，使業績低於管理層預期。

管理層表示減阻劑需求應保持強勁。墨西哥仍是潛在的長期機會，但截至本次法說會，Innospec 在當地尚未錄得任何銷售紀錄。

管理層展望

• 特種化學品部門第四季業績預計與第三季相近。管理層認為北卡羅來納州工廠的升級對釋放 2027 年的成長潛力至關重要。
• 隨著中東客戶活動開始復甦，油田服務部門第四季業績預計將實現季增。
• 燃料特殊化學品部門第四季的毛利率水準預計將與第三季保持大致一致。
• 管理層預估第四季自由現金流約為 4,000 萬至 5,000 萬美元，主因年初至今的部分營運資金投資將出現迴轉。
• 在原料環境相對穩定的情況下，公司預計 2027 年自由現金流將接近 5,500 萬至 6,000 萬美元，對營運資金投資的需求亦將減少。
• 2026 年資本支出預計約為 6,000 萬美元。

風險與關注焦點

中東地緣安全局勢延誤了 Innospec 傳統油田服務營運的現場活動。復甦速度將取決於鑽井平台恢復作業的進度，以及公司恢復客戶服務的能力。

由於業務成長、原料與運費通膨以及庫存增加，營運資金自年初以來擴增了約 8,000 萬美元。管理層坦承庫存可能高於最佳水準，應收帳款需要進行更嚴格的管理。

特種化學品部門的銷量仍低於去年同期。雖然北卡羅來納州工廠的升級按計畫進行，但管理層預期客戶與銷售額的復甦將是漸進式的。

原料與運費波動對燃料特殊化學品部門仍具影響。合約轉嫁機制雖有助於管理這些成本，但包含時間滯後性。

分析師問答亮點

分析師重點關注中東中斷情況、北卡羅來納州工廠升級、價格轉嫁能力及現金產生能力。

管理層指出，中東的中斷主要影響生產與增產刺激業務，而非減阻劑業務。財務影響在部門總業績中的占比並不算高，但仍足以影響油田服務部門的整體表現。

關於特種化學品部門，管理層確認升級時程表沒有實質變動。首要任務是恢復產品供應，其次是改善效率、良率、產能及防寒冬化。該過程無需客戶重新認證。

關於現金流，隨著營運資金正常化，管理層預計第四季將有顯著改善。Innospec 無債務的資產負債表為有機投資、併購、股利成長及股票回購提供了靈活性。

完整法說會逐字稿

完整財報電話會議逐字稿

管理層陳述

Operator

Good day, and thank you for standing by. Welcome to the Innospec's Third Quarter 2026 Earnings Release and Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead.

David Jones

Thank you. Welcome to Innospec's quarterly earnings call. This is David Jones, and I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website.

During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's filings with the SEC. Please see the SEC site and Innospec's site for these and related documents.

In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the company's performance and anticipated impact that these items and events had on financial results.

With me today from Innospec are Patrick Williams, President and Chief Executive Officer; and Ian Cleminson, Executive Vice President and Chief Financial Officer. And with that, I'll turn it over to you, Patrick.

Patrick Williams

Thank you, David, and welcome, everyone, to Innospec's Third Quarter 2026 Conference Call. This was a strong quarter for Innospec with all businesses delivering sales growth and operating income improvement. Performance Chemicals sales growth and gross margin improvement drove an 84% operating income increase over last year. The North Carolina plant efficiency upgrades discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity and yields on a wide range of existing personal care and other products.

In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters.

Fuel Specialties had another strong quarter, delivering revenue and operating income growth with margins in our target range. Both volume and price/mix improved as the business has continued to manage well against raw material volatility. We expect continued strong performance and seasonal demand in the coming quarters.

Oilfield Services operating income grew 40% and operating margins expanded driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected on activity delays in our Middle East legacy business, along with elevated raw material costs. We expect sequential improvement in the fourth quarter.

Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions. Ian?

Ian Cleminson

Thanks, Patrick. Turning to Slide 7 in the presentation. The company's total revenues for the third quarter were $473.6 million, a 7% increase from $441.9 million a year ago. Overall gross margin increased by 0.9 percentage points from last year to 27.3%.

Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million last year, and net income attributable to Innospec for the quarter was $31.8 million compared to $12.9 million a year ago.

Our GAAP earnings per share were $1.29, and there was no net impact of special items in the quarter.

Last year, we reported GAAP earnings per share of $0.52, which included a negative impact from special items of $0.60 per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.29 compared to $1.12 a year ago.

Turning to Slide 8. Revenues in Performance Chemicals for the third quarter were $180.5 million, up 6% from last year's $170.8 million. Volume reductions of 5% and a negative currency impact of 1% were offset by a positive price/mix of 12%, driven by higher raw material pricing.

Gross margins of 18.8% increased 3.7 percentage points compared to 15.1% in the same quarter in 2025.

Operating income of $16.9 million increased 84% from $9.2 million last year. We expect the fourth quarter results to be similar to this quarter with the plant upgrades in North Carolina the key to unlocking growth in 2027.

Moving on to Slide 9. Revenues in Fuel Specialties for the third quarter were $180.7 million, up 5% from $172 million reported a year ago. Volumes were up 3% with price/mix up 2%.

Fuel Specialties gross margins of 31.5% decreased 0.5 percentage points compared to 35.6% in the same quarter last year.

Operating income of $35.6 million was up 1% from $35.3 million a year ago.

Moving on to Slide 10. Revenues in Oilfield Services for the quarter were $112.4 million, up 13% from the $99.1 million reported a year ago.

Gross margins of 28.2% decreased 1.8 percentage points from last year's 30% on a weaker sales mix.

Operating income of $6.7 million increased 40% from $4.8 million 1 year ago.

Turning to Slide 11. Corporate costs for the quarter were $18.6 million compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7% compared to 22.7% last year.

Moving on to Slide 12. Cash from operating activities was $17.4 million before capital expenditures of $15.6 million. As of September 30, Innospec had $251.9 million in cash and cash equivalents and no debt.

And now I'll turn it back over to Patrick for some final comments. Patrick?

Patrick Williams

Thanks, Ian. Again, this quarter, Innospec delivered strong sales and operating income growth with higher margins. Performance Chemicals and Oilfield Services remain our key focus. We expect continued steady and strong results in Fuel Specialties. Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency.

We have significant balance sheet flexibility for organic investment, M&A, dividend growth and buybacks. This quarter, our Board approved a further increase in our semiannual dividend to $0.94 per share, resulting in an annual dividend increase of 9%.

Now I will turn the call over to the operator, and Ian and I will take your questions.

Operator

[Operator Instructions] We are now going to take our first question, and this one comes from Jon Tanwanteng from CJS Securities.

分析師問答

Jonathan Tanwanteng

I was wondering if you could quantify the impact in the oilfield business from delays in the Mid East. And I'm assuming that, that was pipeline attacks in Saudi, number one, in the quarter? And number two, how you expect that business to trend in Q4, assuming a recovery there and the underlying inflation dynamics?

Patrick Williams

Yes, Jon, it's Patrick. It wasn't necessarily impacting the DRA business. More of the impact was on production and stim, and it's just the fact of getting people out in the fields to work while you're having drones bombing over the top of you has been a very difficult situation for that whole area. And the key for us really is making sure that we're back on these rigs when they go back out and that we're servicing the way they need to be serviced.

The impact is probably -- it was probably not a significant percentage, but big enough to make a difference in oilfield. And the hope is from what we're seeing as long as we service the customers as we expect and we have the technology is that we're starting to see some return in business in the fourth quarter, which should really help us out moving forward.

Jonathan Tanwanteng

Got it. And as you head into '27, could you just update us on the outlook for the segment in the coming year, especially if you have potential customers coming in from Latin America and as the dynamic evolves from pipelines to maybe a reopening of the Strait or some other condition change in the Middle East?

Patrick Williams

Yes. So I'll work backwards. If we just stick with the Middle East for a minute, I think that with everything that's going on in that area and other businesses that we're going after, our DRA should remain strong even if the Strait and we have settlements for the Strait of Hormuz than we move forward.

If you look at the general business, we're still waiting to see things move in Latin America. Specific to Mexico, I think you've seen some announcements by President Shinbaum about opening up and putting more money into petrochemicals and petrochemical facilities. And to do that, they've got to fix their crude issue. We're hoping at some time that, that turns, but we have not had any sales into Mexico to date. So it's -- if we had the crystal ball, if all these things came into place, it would obviously look a lot different than it is today. But we still see significant growth -- sequential growth as well moving forward and not [indiscernible] quarter, but in the quarters moving forward in 2027.

Jonathan Tanwanteng

Okay. Great. Next for me, just could you just update us on your expectations for cash and cash flow? You've come down in your net cash balance over the past year. And recognizing you've returned a lot of cash to shareholders, a great job there. But I was wondering if you had any thoughts on where your net cash balance is going to be over the coming year, and how you expect the spending priorities to change, if at all?

Ian Cleminson

Yes. Let me take that one, Jon, it's Ian. What we've seen so far year-to-date is quite a large investment in our working capital. That's expanded by about $80 million since the start of the year. In the fourth quarter, we expect some of that to reverse. And what's driven that is partly the expansion of the business and partly some of the inflation that we've seen coming through the supply chain in terms of raw materials and freights, and that's worked itself through. But no doubt, we're probably carrying a little bit too much inventory. We can be a little bit tighter on some of those receivables. So we've got some work to do in the fourth quarter.

Our view is that we will be much more cash generative in the fourth quarter to the region of about $40 million to $50 million at the free cash flow level. So that takes care of this year. And as we roll into next year, our expectation is that we won't need -- on a stable background with raw materials, relatively stable, we won't need the same level of working capital investment. So we would imagine that we'll be hitting closer to $55 million to $60 million of free cash flow next year. And that's based on a pretty similar level of capital expenditure, around about $60 million last year, and we expect about $60 million this year as well.

Operator

We are now going to take our next question, and this one is from Mike Harrison from Seaport Research Partners.

Michael Harrison

Apologies if I missed it, but a couple of questions on personal care. It sounds like you're expecting the North Carolina plant upgrades to be complete by year-end. I'm just wondering, has the timing moved later there? And if so, what's causing the delays? And I guess the other piece of that question is, is there a requalification process that you need to go through with your customers? Or should we see sales volumes kind of getting back to normal by Q1?

Patrick Williams

Yes, Mike, it's Patrick. We haven't really -- the timing has been about what we expected. The number one priority was to get the plants up and running so that we could provide products to our customers, and that's what we did. The secondary part of the plan was to make sure that we concluded and finished the efficiencies of the plant to make it better, better yields, providing more volume because you have better yields, et cetera, winterizing it, all the things that we had to do. Our number one priority was to get product to our customers. And so the timing of that is exactly what we thought that we would complete all of this by the fourth quarter, and that should happen.

So in regards to recapturing more products or lost sales, I should say, it's going to take some time. We don't have to requalify, but it is going to take some time to go back and recapture some of that business. And that's why we see this -- we do see sequential growth moving forward, but it's just -- it's not going to be that big spike. It's going to be a nice slow curve upwards. And I think the other thing that we're focusing on, too, is the product mix that we put on that plan. We don't want to just load it up with commodity products. We want new products, new technologies that require or we get higher margins from, and that's really the plan moving forward. So it's a plan we've had in place. We're sticking to it. I think the strategy is working, and it should work moving forward in 2027.

Michael Harrison

All right. Very helpful. And then my other question is on the Fuel Specialties business. You guys have these contractual pricing pass-throughs. It looks like price was only up about 2% year-on-year despite what I assume was pretty meaningful raw material inflation. I was just hoping you could talk a little bit about the timing of that pricing pass-through and how that's impacting the margins, either gross margin or operating margin as you look at Fuel Specialties for Q3 and Q4?

Ian Cleminson

Yes, Mike, I'll take that one. We think the Fuel Specialties team has done a good job actually. They've been battling against some really volatile raw material pricing and freight pricing as well. We have managed the gross margins in that business really well. We are 0.5 percentage point down year-over-year. And as you know, we've got all the mechanisms in place as raw materials come through, and there's a little bit of a lag in there. So the level we're at in the fourth (sic) [ third ] quarter is the level we expect to be at in the fourth quarter. We don't see much change there. We think the business has got a handle on it, and we're in control of all of that. So we don't -- I take your point that the price/mix is not up that much, but it's certainly at the gross margin level and the gross profit dollars and the operating income level and the operating margin levels, we're happy where the business is at.

Patrick Williams

And I think, Mike, just to add a little color to what Ian said. I started out with this business and ran this business for quite some time. And we have seen these markets up and down. We've seen high inflation. We've seen recessions. We've seen mega market movements. And it's never been these big run-ups on margins or big rundown on margins. It's always a very well managed and a lot of it's contracts, but it's a very well-managed margin business. So you're never going to see these big spikes in that business. It's just a very stable business, and we've seen that for as long as we've been ahead.

Operator

There are no further questions for today. I will now hand the call back to Patrick Williams for closing remarks.

Patrick Williams

Thank you all for joining us today, and thanks to all our shareholders, customers and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our fourth quarter 2026 results in February. Have a great day.

Operator

Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.